The Japanese pharmaceutical company Taiho Pharmaceutical is set to acquire the Swiss antibody-drug conjugate (ADC) company Araris Biotech for $400 million. Taiho and Araris have been collaborating to ...

Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Consumer Services, Technology and Basic ...